Finally got the webcast working on their website.They are...

Finally got the webcast working on their website.

They are anticipating an average or mild flu season in the northern hemisphere but still reckon their 140 sites should complete the Lani trial on time.

Looks like the RSV program is chugging along. Maybe IND studies 1st half next year. Once a day oral dosing sounds very promising. I could fall in love with Biota if they got this program back on the rails quicksmart.

No mention of Gyrase.

They are not very keen on Vapendavir lol. Note to PC (if he wants to run another biotech company) focus on drugs that have simple regulatory pathways.

The last person (1 of 2 people) asking the questions asked the typical numpty question.